Header Logo

Connection

Michelle Callegan to Disease Models, Animal

Back to Details
This is a "connection" page, showing publications Michelle Callegan has written about Disease Models, Animal.
Michelle Callegan
Connection Strength
3.184
Disease Models, Animal
  1. Novel Anti-Microbial/Anti-Inflammatory Combination Improves Clinical Outcome of Bacillus cereus Endophthalmitis. Invest Ophthalmol Vis Sci. 2025 Jan 02; 66(1):39.
    View in: PubMed
    Score: 0.632
  2. The Role of CCL Chemokines in Experimental Staphylococcus aureus Endophthalmitis. Invest Ophthalmol Vis Sci. 2024 Jun 03; 65(6):12.
    View in: PubMed
    Score: 0.607
  3. Modeling intraocular bacterial infections. Prog Retin Eye Res. 2016 09; 54:30-48.
    View in: PubMed
    Score: 0.346
  4. Contribution of Leukocidin ED to the Pathogenesis of Staphylococcus aureus Endophthalmitis. Invest Ophthalmol Vis Sci. 2025 May 01; 66(5):11.
    View in: PubMed
    Score: 0.161
  5. C-X-C Chemokines Influence Intraocular Inflammation During Bacillus Endophthalmitis. Invest Ophthalmol Vis Sci. 2021 11 01; 62(14):14.
    View in: PubMed
    Score: 0.127
  6. Immune Inhibitor A Metalloproteases Contribute to Virulence in Bacillus Endophthalmitis. Infect Immun. 2021 09 16; 89(10):e0020121.
    View in: PubMed
    Score: 0.123
  7. Intravitreal Injection and Quantitation of Infection Parameters in a Mouse Model of Bacterial Endophthalmitis. J Vis Exp. 2021 02 06; (168).
    View in: PubMed
    Score: 0.120
  8. Innate Immune Interference Attenuates Inflammation In Bacillus Endophthalmitis. Invest Ophthalmol Vis Sci. 2020 11 02; 61(13):17.
    View in: PubMed
    Score: 0.118
  9. Bacillus S-Layer-Mediated Innate Interactions During Endophthalmitis. Front Immunol. 2020; 11:215.
    View in: PubMed
    Score: 0.112
  10. The role of pili in Bacillus cereus intraocular infection. Exp Eye Res. 2017 06; 159:69-76.
    View in: PubMed
    Score: 0.092
  11. Blood-Retinal Barrier Compromise and Endogenous Staphylococcus aureus Endophthalmitis. Invest Ophthalmol Vis Sci. 2015 Nov; 56(12):7303-11.
    View in: PubMed
    Score: 0.084
  12. Role of TLR5 and flagella in bacillus intraocular infection. PLoS One. 2014; 9(6):e100543.
    View in: PubMed
    Score: 0.076
  13. TLR4 contributes to the host response to Klebsiella intraocular infection. Curr Eye Res. 2014 Aug; 39(8):790-802.
    View in: PubMed
    Score: 0.074
  14. The diabetic ocular environment facilitates the development of endogenous bacterial endophthalmitis. Invest Ophthalmol Vis Sci. 2012 Nov 01; 53(12):7426-31.
    View in: PubMed
    Score: 0.068
  15. Efficacy of vitrectomy in improving the outcome of Bacillus cereus endophthalmitis. Retina. 2011 Sep; 31(8):1518-24.
    View in: PubMed
    Score: 0.063
  16. Contribution of mucoviscosity-associated gene A (magA) to virulence in experimental Klebsiella pneumoniae endophthalmitis. Invest Ophthalmol Vis Sci. 2011 Aug 29; 52(9):6860-6.
    View in: PubMed
    Score: 0.063
  17. Hypermucoviscosity as a virulence factor in experimental Klebsiella pneumoniae endophthalmitis. Invest Ophthalmol Vis Sci. 2008 Nov; 49(11):4931-8.
    View in: PubMed
    Score: 0.050
  18. Toward improving therapeutic regimens for Bacillus endophthalmitis. Invest Ophthalmol Vis Sci. 2008 Apr; 49(4):1480-7.
    View in: PubMed
    Score: 0.049
  19. Acute inflammation and loss of retinal architecture and function during experimental Bacillus endophthalmitis. Curr Eye Res. 2006 Nov; 31(11):955-65.
    View in: PubMed
    Score: 0.045
  20. Contribution of membrane-damaging toxins to Bacillus endophthalmitis pathogenesis. Infect Immun. 2002 Oct; 70(10):5381-9.
    View in: PubMed
    Score: 0.034
  21. Kallistatin Attenuates Experimental Autoimmune Uveitis by Inhibiting Activation of T Cells. Front Immunol. 2020; 11:975.
    View in: PubMed
    Score: 0.029
  22. Ocular Glands Become Infected Secondarily to Infectious Keratitis and Play a Role in Corneal Resistance to Infection. J Virol. 2019 08 15; 93(16).
    View in: PubMed
    Score: 0.027
  23. Caveolin-1 increases proinflammatory chemoattractants and blood-retinal barrier breakdown but decreases leukocyte recruitment in inflammation. Invest Ophthalmol Vis Sci. 2014 Aug 26; 55(10):6224-34.
    View in: PubMed
    Score: 0.019
  24. Methicillin-resistant Staphylococcus aureus keratitis in the rabbit: therapy with ciprofloxacin, vancomycin and cefazolin. Curr Eye Res. 1992 Nov; 11(11):1111-9.
    View in: PubMed
    Score: 0.017
  25. Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis. Invest Ophthalmol Vis Sci. 1992 Oct; 33(11):3017-23.
    View in: PubMed
    Score: 0.017
  26. The SAG1 Toxoplasma gondii surface protein is not required for acute ocular toxoplasmosis in mice. Infect Immun. 2007 Apr; 75(4):2079-83.
    View in: PubMed
    Score: 0.011
  27. The effectiveness of two ciprofloxacin formulations for experimental Pseudomonas and Staphylococcus keratitis. Jpn J Ophthalmol. 1996; 40(2):212-9.
    View in: PubMed
    Score: 0.005
  28. Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis. Curr Eye Res. 1995 Mar; 14(3):229-34.
    View in: PubMed
    Score: 0.005
  29. Pseudomonas aeruginosa keratitis in leukopenic rabbits. Curr Eye Res. 1993 May; 12(5):461-7.
    View in: PubMed
    Score: 0.004
  30. Prednisolone acetate or prednisolone phosphate concurrently administered with ciprofloxacin for the therapy of experimental Pseudomonas aeruginosa keratitis. Curr Eye Res. 1993 May; 12(5):469-73.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.